Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece.
Georgopoulos S, Papastergiou V, Xirouchakis E, Laudi F, Papantoniou N, Lisgos P, Spiliadi C, Fragou P, Skorda L, Karatapanis S. Georgopoulos S, et al. Among authors: papastergiou v. Helicobacter. 2012 Feb;17(1):49-53. doi: 10.1111/j.1523-5378.2011.00911.x. Helicobacter. 2012. PMID: 22221616 Clinical Trial.
Hybrid therapy as first-line regimen for Helicobacter pylori eradication in a high clarithromycin resistance area: a prospective open-label trial.
Georgopoulos SD, Papastergiou V, Martinez-Gonzalez B, Xirouchakis E, Familias I, Sgouras D, Mentis A, Karatapanis S. Georgopoulos SD, et al. Among authors: papastergiou v. Ann Gastroenterol. 2018 Mar-Apr;31(2):205-210. doi: 10.20524/aog.2017.0221. Epub 2017 Dec 15. Ann Gastroenterol. 2018. PMID: 29507467 Free PMC article.
52 results